Business Segments · Selling, general, and administrative expenses

Japan — Selling, general, and administrative expenses

Edwards Lifesciences Japan — Selling, general, and administrative expenses decreased by 38.1% to $15.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.0%, from $16.40M to $15.90M. Over 3 years (FY 2022 to FY 2025), Japan — Selling, general, and administrative expenses shows relatively stable performance with a 0.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026
Rolls up toSG&A

How to read this metric

A decrease relative to revenue suggests improved operating leverage, while a significant increase may indicate aggressive investment in market expansion or rising administrative overhead.

Detailed definition

This metric aggregates the operating expenses required to support the sales, marketing, and administrative functions spe...

Peer comparison

Comparable to regional SG&A allocations in global medical device companies.

Metric ID: ew_segment_japan_selling_general_and_administrative_expenses

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$19.35M$19.35M$19.35M$19.35M$17.53M$17.53M$17.53M$17.53M$26.00M$19.60M$17.70M$21.80M$16.40M$18.50M$17.90M$25.70M$15.90M
QoQ Change+0.0%+0.0%+0.0%-9.4%+0.0%+0.0%+0.0%+48.4%-24.6%-9.7%+23.2%-24.8%+12.8%-3.2%+43.6%-38.1%
YoY Change-9.4%-9.4%-9.4%-9.4%+48.4%+11.8%+1.0%+24.4%-36.9%-5.6%+1.1%+17.9%-3.0%
Range$15.90M$26.00M
CAGR-4.8%
Avg YoY Growth+1.6%
Median YoY Growth-3.0%

Frequently Asked Questions

What is Edwards Lifesciences's japan — selling, general, and administrative expenses?
Edwards Lifesciences (EW) reported japan — selling, general, and administrative expenses of $15.90M in Q1 2026.
How has Edwards Lifesciences's japan — selling, general, and administrative expenses changed year-over-year?
Edwards Lifesciences's japan — selling, general, and administrative expenses decreased by 3.0% year-over-year, from $16.40M to $15.90M.
What is the long-term trend for Edwards Lifesciences's japan — selling, general, and administrative expenses?
Over 3 years (2022 to 2025), Edwards Lifesciences's japan — selling, general, and administrative expenses has grown at a 0.5% compound annual growth rate (CAGR), from $77.40M to $78.50M.
What does japan — selling, general, and administrative expenses mean?
Operating costs related to selling and administrative activities in Japan.